These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36896170)

  • 1. Identification of biomarkers and prediction of upstream miRNAs in diabetic nephropathy.
    Yin D; Guo Z; Zhang X
    Front Endocrinol (Lausanne); 2023; 14():1144331. PubMed ID: 36896170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of tubulointerstitial genes and ceRNA networks involved in diabetic nephropathy via integrated bioinformatics approaches.
    Cao H; Rao X; Jia J; Yan T; Li D
    Hereditas; 2022 Sep; 159(1):36. PubMed ID: 36154667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
    Guo M; Dai Y; Jiang L; Gao J
    Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
    Dai Y; Guo M; Jiang L; Gao J
    Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis.
    Hu Y; Yu Y; Dong H; Jiang W
    PeerJ; 2023; 11():e15437. PubMed ID: 37250717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seven basement membrane-specific expressed genes are considered potential biomarkers for the diagnosis and treatment of diabetic nephropathy.
    Gui H; Chen X; Ye L; Ma H
    Acta Diabetol; 2023 Apr; 60(4):493-505. PubMed ID: 36627452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy.
    Ming J; Sana SRGL; Deng X
    Front Endocrinol (Lausanne); 2022; 13():978601. PubMed ID: 36329882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Lipotoxicity-Related Biomarkers in Diabetic Nephropathy Based on Bioinformatic Analysis.
    Nie H; Yang H; Cheng L; Yu J
    J Diabetes Res; 2024; 2024():5550812. PubMed ID: 38774257
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening of the Key Genes and Signalling Pathways for Diabetic Nephropathy Using Bioinformatics Analysis.
    Li Z; Feng J; Zhong J; Lu M; Gao X; Zhang Y
    Front Endocrinol (Lausanne); 2022; 13():864407. PubMed ID: 35923621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTGER3 and MMP-2 play potential roles in diabetic nephropathy via competing endogenous RNA mechanisms.
    Yu Y; Jia YY; Wang M; Mu L; Li HJ
    BMC Nephrol; 2021 Jan; 22(1):27. PubMed ID: 33435900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.
    Gholaminejad A; Fathalipour M; Roointan A
    BMC Nephrol; 2021 Jul; 22(1):245. PubMed ID: 34215202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of miRNAs-genes regulatory network in diabetic nephropathy based on bioinformatics analysis.
    Yang F; Cui Z; Deng H; Wang Y; Chen Y; Li H; Yuan L
    Medicine (Baltimore); 2019 Jul; 98(27):e16225. PubMed ID: 31277135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets.
    Hojjati F; Roointan A; Gholaminejad A; Eshraghi Y; Gheisari Y
    Nefrologia (Engl Ed); 2023; 43(5):575-586. PubMed ID: 36681521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the Mechanism of Complement System in Diabetic Nephropathy via Bioinformatics Analysis.
    Xu B; Wang L; Zhan H; Zhao L; Wang Y; Shen M; Xu K; Li L; Luo X; Zhou S; Tang A; Liu G; Song L; Li Y
    J Diabetes Res; 2021; 2021():5546199. PubMed ID: 34124269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key Genes Involved in Diabetic Nephropathy Investigated by Microarray Analysis.
    Liu X; Li X
    J Comput Biol; 2019 Dec; 26(12):1438-1447. PubMed ID: 31356112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies.
    Gholaminejad A; Abdul Tehrani H; Gholami Fesharaki M
    J Nephrol; 2018 Dec; 31(6):813-831. PubMed ID: 30019103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of mitochondria-related genes as diagnostic biomarkers for diabetic nephropathy and their correlation with immune infiltration: New insights from bioinformatics analysis.
    Yan Q; Du Y; Huang F; Zhang Q; Zhan M; Wu J; Yan J; Zhang P; Lin H; Han L; Huang X
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113114. PubMed ID: 39265357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Fibrotic Biomarkers Associated with Macrophages in Diabetic Nephropathy.
    Hou R; Gao L; Long J; Cao J; Yin T; Xu J
    Med Sci Monit; 2023 Nov; 29():e940847. PubMed ID: 37964514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the shared molecular mechanism of microvascular and macrovascular complications in diabetes: Seeking the hub of circulatory system injury.
    Yuchen C; Hejia Z; Fanke M; Qixin D; Liyang C; Xi G; Yanxia C; Xiongyi Y; Zhuohang X; Guoguo Y; Min F
    Front Endocrinol (Lausanne); 2023; 14():1032015. PubMed ID: 36755923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VCAM1: an effective diagnostic marker related to immune cell infiltration in diabetic nephropathy.
    Deng Y; Zhang S; Luo Z; He P; Ma X; Ma Y; Wang J; Zheng L; Tian N; Dong S; Zhang X; Zhang M
    Front Endocrinol (Lausanne); 2024; 15():1426913. PubMed ID: 39319258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.